Huafon Chemical Co., Ltd. (002064.SZ)
Wenzhou, ZJ, CN
Huafon Chemical Co., Ltd., a Chinese enterprise established in 1999 and based in Ruian, specializes in the manufacturing and distribution of spandex. Its key product is Qianxi spandex yarn, a flexible polyurethane elastic fiber widely incorporated into diverse applications like underwear, swimwear, socks, jeans, casual athletic wear, medical bandages, fabric ribbons, and diapers. In addition to its primary spandex operations, the company also produces cyclohexanone and other benzene-based chemicals. Its business activities extend to the global trade of textile items, notably spandex fibers, and it also engages in the power and heat cogeneration sector. The firm was previously known as Zhejiang Huafeng Spandex Co., Ltd. before adopting its current name in January 2021.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.94% | -2.41% | -12.92% | -18.53% | +7.44% | -8.09% | +47.81% | +49.12% | -18.34% | +132.95% | +1,102.63% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-10.3% Q1'26: +7.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-17.8% Q1'26: +30.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.6% ★ Q1'26: +3.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.0% Q1'26: +11.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+7.1% ★ Q1'26: +11.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.6% Q1'26: -1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.72× ★ Q1'26: 1.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.55B
est: 3.35B (-24.0%)
|
2.84B
est: 2.84B (+0.0%)
|
4.15B
est: 3.82B (+8.8%)
|
15.13B
est: 4.44B (+241.1%)
|
13.79B
est: 12.41B (+11.1%)
|
14.72B
est: 15.13B (-2.7%)
|
28.37B
est: 28.61B (-0.8%)
|
25.88B
est: 24.85B (+4.1%)
|
26.30B
est: 23.56B (+11.6%)
|
26.93B
est: 25.32B (+6.4%)
|
24.16B
est: 24.03B (+0.6%)
|
28.45B
27.99B – 28.91B
+18.4% YoY
|
29.84B
28.40B – 30.62B
+4.9% YoY
|
31.78B
30.76B – 32.46B
+6.5% YoY
|
| EBITDA |
583.78M
est: 683.38M (-14.6%)
|
372.09M
est: 579.81M (-35.8%)
|
772.18M
est: 777.77M (-0.7%)
|
2.88B
est: 904.27M (+218.6%)
|
2.70B
est: 2.53B (+6.5%)
|
3.44B
est: 3.08B (+11.5%)
|
10.12B
est: 5.83B (+73.6%)
|
3.81B
est: 5.07B (-24.8%)
|
3.69B
est: 4.80B (-23.2%)
|
3.82B
est: 4.71B (-18.9%)
|
3.46B
est: 4.47B (-22.5%)
|
5.29B
5.20B – 5.37B
+18.4% YoY
|
5.54B
5.28B – 5.69B
+4.9% YoY
|
5.91B
5.72B – 6.03B
+6.5% YoY
|
| EBIT |
355.43M
est: 525.68M (-32.4%)
|
118.48M
est: 446.01M (-73.4%)
|
479.65M
est: 598.29M (-19.8%)
|
2.26B
est: 695.60M (+225.4%)
|
2.08B
est: 1.95B (+7.0%)
|
2.60B
est: 2.37B (+9.5%)
|
9.16B
est: 4.49B (+104.2%)
|
2.76B
est: 3.90B (-29.2%)
|
2.41B
est: 3.69B (-34.6%)
|
2.32B
est: 3.48B (-33.2%)
|
1.93B
est: 3.30B (-41.7%)
|
3.91B
3.85B – 3.97B
+18.4% YoY
|
4.10B
3.90B – 4.21B
+4.9% YoY
|
4.37B
4.23B – 4.46B
+6.5% YoY
|
| Net Income |
254.13M
est: 1.43B (-82.2%)
|
-303.81M
est: -986.65M (+69.2%)
|
385.50M
est: 1.13B (-66.0%)
|
1.94B
est: 1.28B (+51.0%)
|
1.84B
est: 1.85B (-0.6%)
|
2.28B
est: 2.44B (-6.7%)
|
7.94B
est: 8.39B (-5.4%)
|
2.84B
est: 2.83B (+0.4%)
|
2.48B
est: 2.57B (-3.4%)
|
2.22B
est: 2.43B (-8.7%)
|
1.86B
est: 1.97B (-5.5%)
|
3.08B
2.95B – 3.17B
+56.9% YoY
|
3.67B
3.51B – 3.77B
+18.9% YoY
|
4.25B
4.07B – 4.36B
+15.8% YoY
|
| SGA |
274.83M
est: 82.08M (+234.8%)
|
294.23M
est: 69.64M (+322.5%)
|
210.98M
est: 93.41M (+125.9%)
|
702.85M
est: 108.61M (+547.1%)
|
724.35M
est: 303.90M (+138.3%)
|
453.14M
est: 370.43M (+22.3%)
|
595.68M
est: 700.47M (-15.0%)
|
618.33M
est: 608.58M (+1.6%)
|
624.33M
est: 576.79M (+8.2%)
|
620.16M
est: 581.60M (+6.6%)
|
560.29M
est: 551.95M (+1.5%)
|
653.47M
642.98M – 663.97M
+18.4% YoY
|
685.32M
652.33M – 703.40M
+4.9% YoY
|
730.03M
706.49M – 745.56M
+6.5% YoY
|
| EPS |
0.15
est: 0.29 (-48.3%)
|
-0.18
est: -0.20 (+10.0%)
|
0.23
est: 0.23 (+0.0%)
|
1.16
est: 0.26 (+346.2%)
|
0.43
est: 0.38 (+14.4%)
|
0.49
est: 0.50 (-1.0%)
|
1.71
est: 1.70 (+0.6%)
|
0.58
est: 0.57 (+1.0%)
|
0.50
est: 0.52 (-3.8%)
|
0.45
est: 0.49 (-8.2%)
|
0.37
est: 0.40 (-6.6%)
|
0.62
0.60 – 0.64
+56.9% YoY
|
0.74
0.71 – 0.76
+18.9% YoY
|
0.86
0.82 – 0.88
+15.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.19% | 68.3K | 0.65% |
| 2 | iShares MSCI China A ETF CNYA | 0.11% | 246.1K | 0.60% |
| 3 | iShares MSCI China A UCITS ETF CNYA.L | 0.10% | 3.14M | 0.40% |
| 4 | iShares MSCI China A UCITS ETF CNYE.MI | 0.10% | 103.6K | 0.45% |
| 5 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.10% | 131.6K | 0.35% |
| 6 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.09% | 133.4K | 0.35% |
| 7 | HSBC MSCI China A UCITS ETF HMCT.L | 0.09% | 122.0K | 0.30% |
| 8 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.07% | 11.1K | 0.65% |
| 9 | JPMorgan ETFs (Ireland) ICAV - China A Research Enhanced Index Equity Active UCITS ETF JREC.L | 0.05% | 12.5K | 0.40% |
| 10 | Invesco MSCI China All Shares Stock Connect UCITS ETF MCHN.L | 0.05% | 54.1K | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jie Sun | Financial Director & Accounting Supervisor | — | female |
| Ning Xu | Deputy General Manager | — | male |
| Suojun Zhang | Deputy General Manager | — | male |
| Xiaoyin Yang | Deputy General Manager | — | male |
| Xuanxiang Zhu | GM & Director | — | male |
| Yilun Li | Board Secretary | — | female |
| Zhili Yu | Executive Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002064.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
